Compare MACOM Technology (MTSI) vs Novo Nordisk A/S (NVO) Price & Performance

MACOM TechnologyTrade

Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

MACOM Technology vs Novo Nordisk A/S — how do they compare? MACOM Technology trades at $284.01 (market cap $20.99B), while Novo Nordisk A/S trades at $44.69 (market cap $200.69B). The key difference: Novo Nordisk A/S is far larger — about 9.6× MACOM Technology's market cap, and Novo Nordisk A/S pays a 3.98% dividend while MACOM Technology pays none. Which is the better fit depends on your goals.

	MTSI	NVO
Market Cap	$20.99B	$200.69B
Sector	Technology	Health
52-Week High	$409.68	$63.98
52-Week Low	$122.18	$35.29
Enterprise Value	$20.70B	$215.49B
Dividend Yield	—	3.98%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MACOM Technology

No Aura AI signal available yet.

Novo Nordisk A/S

Novo Nordisk (NVO) trades at $45.16, down 3.09% today, with bearish technical signals but strong fundamentals. The stock shows robust profitability with 35.35% net margin and 59.82% ROE, supported by consistent earnings beats. Recent developments include positive pediatric obesity trial results for semaglutide and Wegovy pill launch in Germany. Cash flow remains healthy with $10.81B net inflow in 2025, though 2026 projections show a decline.

NVO presents a mixed outlook with strong fundamental metrics offset by technical weakness and competitive pressures. Investment opportunity lies in the expanding GLP-1 market and pipeline developments, while risks include market share loss to Eli Lilly and failed cardiovascular drug trials. Analyst consensus leans bullish with 57.9% buy ratings, but recent prescription slowdown concerns warrant caution.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MTSI

View details →

NVO

Canada imposes retaliatory tariffs on $20B of U.S. goods, escalating trade tensions and impacting North American supply chains.Seeking Alpha · 2 days agoNeutral 4-Factor Dividend Growth Strategy slightly outperforms SCHD with 14.89% returns, testing new variants.Seeking Alpha · 3 days agoBullish View details →

About MACOM Technology

MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.